Prospects for the development of pharmaceutical industry enterprises' activities

The subject of the study is the prospects for the development of pharmaceutical industry enterprises.The purpose of the study is to assess the prospects for the development of pharmaceuticalindustry enterprises, identify the main trends and challenges they face, and develop recommendationsfor improving their functioning in the context of the modern market.Research methods. To achieve the set goal in the study of the prospects for the developmentof pharmaceutical industry enterprises, the following methods were used: the dialectical method ofscientific knowledge – for analyzing the interconnections between various factors influencing thedevelopment of the pharmaceutical industry and their impact on the efficiency of enterprises; theanalytical method – for assessing changes in the activities of pharmaceutical enterprises and theiradaptation to new market conditions; the graphical method – for visualizing the research results; andthe abstract–logical method – for formulating conclusions and developing recommendations for thefurther development of pharmaceutical industry enterprises.Work results. The article examines the prospects for the development of pharmaceutical industryenterprises. It identifies the key factors influencing the production of pharmaceutical products and medicines,including: military conflict, inflation and the devaluation of the national currency, resource redistribution,reduced demand, and supply chain issues with raw materials and components. The main directions forthe development of pharmaceutical industry enterprises are outlined, namely: the implementation ofinnovations and technologies in pharmaceutical production; increasing the level of localization of production;international integration; and improving the accessibility of medicines for the population.Conclusions. The development of pharmaceutical industry enterprises in Ukraine has broadprospects and significant potential for growth and improvement. Innovative technologies, increasingproduction localization, fostering international integration, and ensuring the accessibility of medicinesfor the population can serve as key drivers for the sustainable development of the industry. However,to realize these prospects, it is important to consider various challenges such as economic instability,external economic factors, as well as the need to modernize production capacities and improve productquality. Successful adaptation of pharmaceutical enterprises to new conditions, investment in newtechnologies, and the implementation of social and environmental standards will not only strengthenthe national economy but also contribute to improving public health, ensuring reliable and affordablemedical care for all segments of the population.